Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Revenue

In the year 2025, Axsome Therapeutics had annual revenue of $638.50M with 65.55% growth. Axsome Therapeutics had revenue of $196.00M in the quarter ending December 31, 2025, with 65.03% growth.

• Revenue (ttm): $638.50M
• Revenue Growth: +65.55%
• P/S Ratio: 14.64
• Revenue / Employee: $690,266
• Employees: 925
• Market Cap: 9.35B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	638.50M	252.80M	65.55%
Dec 31, 2024	385.69M	115.09M	42.53%
Dec 31, 2023	270.60M	220.56M	440.80%
Dec 31, 2022	50.04M	-	-
Dec 31, 2021	-	-	-